Family · Pharmaceutical analytical standards
Pramipexole
A non-ergoline dopamine agonist: it stimulates brain receptors for dopamine, the neurotransmitter that runs short in Parkinson's disease. Approved in the United States in 1997, it is also used for restless legs syndrome. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards, nitrosamines and other impurities.
Did you know?Its mirror image, dexpramipexole, has almost no dopamine activity but lowers eosinophils in the blood: for this reason it has been studied for eosinophilic asthma.
No product matches your search.
EDQM standards 3
The official European Pharmacopoeia standards for this family.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
